Candriam SCA’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Candriam SCA’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$199K	–	730
2023 Q3	$199K	Buy	10,000 +1,000	+11%	+$236K	﹤0.01%	653
2023 Q2	$2.57M	Sell	9,000 -7,441	-45%	-$2.07M	0.02%	453
2023 Q1	$3.28M	Buy	16,441 +2,630	+19%	+$512K	0.02%	460
2022 Q4	$2.84M	Buy	13,811 +2,513	+22%	+$635K	0.02%	506
2022 Q3	$3.14M	Sell	11,298 -12,102	-52%	-$3.08M	0.02%	491
2022 Q2	$4.47M	Buy	23,400 +5,000	+27%	+$883K	0.04%	338
2022 Q1	$3.81M	Buy	18,400 +4,000	+28%	+$659K	0.03%	401
2021 Q4	$2.57M	Buy	+14,400	New	+$2.84M	0.02%	498

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Candriam SCA's SWAV Position: Q4 2023 in Review

Candriam SCA sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 10,000 shares — an estimated $199K sold.

Candriam SCA first reported a position in SWAV in Q4 2021 and held it in 8 quarters. The position peaked at $4.47M in Q2 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

Candriam SCA reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Candriam SCA sold 10,000 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $199K.
Candriam SCA first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Candriam SCA's Shockwave Medical, Inc. Common Stock position peaked at $4.47M in Q2 2022.
427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.